ALLOS THERAPEUTICS INC Net Income
ALLOS THERAPEUTICS INC reported Net Income of -$7.97 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Income Statement
us-gaap:NetIncomeLoss · last filed 2012-08-03
- ALLOS THERAPEUTICS INC net income (loss) attributable to parent for the quarter ending 2012-06-30 was -$7.97M.
- ALLOS THERAPEUTICS INC net income (loss) attributable to parent for the quarter ending 2012-03-31 was -$11.32M.
- ALLOS THERAPEUTICS INC net income (loss) attributable to parent for the quarter ending 2011-12-31 was -$1.42M.
- ALLOS THERAPEUTICS INC net income (loss) attributable to parent for the quarter ending 2011-09-30 was -$11.39M.
- ALLOS THERAPEUTICS INC net income (loss) attributable to parent for fiscal 2011 was -$30.53M.
- ALLOS THERAPEUTICS INC net income (loss) attributable to parent for fiscal 2010 was -$77.42M.
- ALLOS THERAPEUTICS INC net income (loss) attributable to parent for fiscal 2009 was -$73.55M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|---|---|---|
| 2012-06-30 | -$7.97M 10-Q · filed 2012-08-03 | -$19.29M 10-Q · filed 2012-08-03 | -$20.71M derived: sum of 3 quarters · filed 2012-08-03 | -$32.10M derived: sum of 4 quarters · filed 2012-08-03 | |||
| 2012-03-31 | -$11.32M 10-Q · filed 2012-05-03 | -$12.74M derived: sum of 2 quarters · filed 2012-05-03 | -$24.13M derived: sum of 3 quarters · filed 2012-05-03 | -$26.64M derived: sum of 4 quarters · filed 2012-08-03 | |||
| 2011-12-31 | -$1.42M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-26 | -$12.81M derived: sum of 2 quarters · filed 2012-03-26 | -$15.32M derived: sum of 3 quarters · filed 2012-08-03 | -$30.53M 10-K · filed 2012-03-26 | |||
| 2011-09-30 | -$11.39M 10-Q/A · filed 2012-03-26 | -$11.25M 10-Q · filed 2011-11-03 | -$13.90M derived: sum of 2 quarters · filed 2012-08-03 | -$29.10M 10-Q/A · filed 2012-03-26 | -$24.29M 10-Q · filed 2011-11-03 | -$47.25M derived: sum of 4 quarters · filed 2012-08-03 | |
| 2011-06-30 | -$2.51M 10-Q · filed 2012-08-03 | $2.16M 10-Q · filed 2011-08-04 | -$17.72M 10-Q · filed 2012-08-03 | -$13.04M 10-Q · filed 2011-08-04 | -$35.86M derived: sum of 3 quarters · filed 2012-08-03 | -$54.63M derived: sum of 4 quarters · filed 2012-08-03 | |
| 2011-03-31 | -$15.20M 10-Q · filed 2012-05-03 | -$33.34M derived: sum of 2 quarters · filed 2012-05-03 | -$52.12M derived: sum of 3 quarters · filed 2012-05-03 | -$72.07M derived: sum of 4 quarters · filed 2012-05-03 | |||
| 2010-12-31 | -$18.14M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-26 | -$36.92M derived: sum of 2 quarters · filed 2012-03-26 | -$56.87M derived: sum of 3 quarters · filed 2012-03-26 | -$77.42M 10-K · filed 2012-03-26 | |||
| 2010-09-30 | -$18.77M 10-Q/A · filed 2012-03-26 | -$38.73M derived: sum of 2 quarters · filed 2012-03-26 | -$59.27M 10-Q/A · filed 2012-03-26 | ||||
| 2010-06-30 | -$19.95M 10-Q/A · filed 2012-03-26 | -$40.50M 10-Q/A · filed 2012-03-26 | |||||
| 2009-12-31 | -$73.55M 10-K · filed 2012-03-26 |